Oxylipin profiling in endothelial cells in vitro – Effects of DHA and hydrocortisone upon an inflammatory challenge

•Oxylipin profiles were measured in an in vitro model of endothelial inflammation.•TNFα/IL-1β triggered the COX pathway and the release of pro-inflammatory oxylipins.•DHA inhibited inflammatory pathways while turning on the pro-resolution program.•Hydrocortisone blunted the release of both inflammat...

Full description

Saved in:
Bibliographic Details
Published inProstaglandins & other lipid mediators Vol. 144; p. 106352
Main Authors Motta, A.C., Strassburg, K., Oranje, P., Vreeken, R.J., Jacobs, D.M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Oxylipin profiles were measured in an in vitro model of endothelial inflammation.•TNFα/IL-1β triggered the COX pathway and the release of pro-inflammatory oxylipins.•DHA inhibited inflammatory pathways while turning on the pro-resolution program.•Hydrocortisone blunted the release of both inflammatory and resolution oxylipins. Omega-3 poly-unsaturated fatty acids have been shown to have beneficial effects on several inflammatory-driven endpoints such as cardiovascular diseases. The anti-inflammatory effects of docosahexaenoic acid (DHA) are largely mediated through various oxylipins. Yet, mechanistic insights are limited. Here, we measured 53 oxylipins using LC-MS/MS in an in vitro model of endothelial cell inflammation, and compared the changes induced by DHA to hydrocortisone, a well-established anti-inflammatory drug. DHA modified several oxylipins derived from different precursors such as DHA, AA, LA and EPA. In response to a TNFα and IL-1-β challenge, DHA clearly reduced many COX-derived pro-inflammatory oxylipins, yet to a minor extent when compared to hydrocortisone. DHA also upregulated metabolites from the CYP and LOX pathways as opposed to hydrocortisone. Thus, DHA reduced pro-inflammation and enhanced pro-resolution, while hydrocortisone blunted both the pro- and anti-inflammatory pathways. Our results may fuel further research on the mitigation of corticosteroids adverse side-effects.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1098-8823
DOI:10.1016/j.prostaglandins.2019.106352